Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1,719.0

€1,719.0

0.350%
6.0
0.350%
€2,150.0
 
09:49 / Tradegate WKN: 885036 / Name: Markel / Stock / Insurance / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Markel Corp. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Markel

sharewise wants to provide you with the best news and tools for Markel, so we directly link to the best financial data sources.

News

Hagerty Q1 Earnings Call Highlights
Hagerty Q1 Earnings Call Highlights

Hagerty (NYSE:HGTY) reported what executives described as its strongest first-quarter performance to date, citing record policy additions, accelerating

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png?w=800&q=75&fit=max&auto=format
Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

On June 23, 2026, Stacy Markel, Chief People Officer at Nuvation Bio Inc. (NYSE:NUVB), exercised 125,000 options for Class A Common Stock and sold the resulting shares for a transaction value of

Markel vs. Skyward: Which Specialty Insurance Stock Is a Better Buy in 2026?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/8cd6be858db5e4ce4620efa120c8f078af15d22a-1200x800.png?w=800&q=75&fit=max&auto=format
Markel vs. Skyward: Which Specialty Insurance Stock Is a Better Buy in 2026?

Insurance stocks can be low volatility growers that offer good income, too. Yet even in the stodgy insurance business, choosing between a seasoned industry leader and an aggressive newcomer is a